The histone H2B ubiquitin ligase RNF40 is required for HER2-driven mammary tumorigenesis

The HER2-positive breast cancer subtype (HER2(+)-BC) displays a particularly aggressive behavior. Anti-HER2 therapies have significantly improved the survival of patients with HER2(+)-BC. However, a large number of patients become refractory to current targeted therapies, necessitating the developme...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cell Death Dis
Asıl Yazarlar: Wegwitz, Florian, Prokakis, Evangelos, Pejkovska, Anastasija, Kosinsky, Robyn Laura, Glatzel, Markus, Pantel, Klaus, Wikman, Harriet, Johnsen, Steven A.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Nature Publishing Group UK 2020
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7568723/
https://ncbi.nlm.nih.gov/pubmed/33070155
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41419-020-03081-w
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller